Researchers at the University of Oxford have launched a human challenge trial to look at what kind of immune response can stop people from becoming re-infected. They also want to see how the immune system reacts second time round. The…
Researchers at the University of Oxford have launched a human challenge trial to look at what kind of immune response can stop people from becoming re-infected. They also want to see how the immune system reacts second time round. The…
A brand new massive randomized control trial has been completed on the treatment of early, outpatient COVID-19 in those high risk for decompensation using a cheap, widely available drug named Colchicine! They found really astounding results including a decreased rate…
Dr Howard Weiner from the Harvard Medical School and Tiziana Life Sciences PLC’s (LON:TILS) (NASDAQ:TLSA) scientific advisory board chairman speaks to Proactive’s Andrew Scott following the news they’ve completed the clinical trial of its nasally administered Foralumab for the treatment…